Volcano Announces U.S. and European Launch of Rotational IVUS and Inte...(D. FSCAIwill begin an 18 city speaking t...)

Date:3/28/2008

D., FSCAI will begin an 18 city speaking tour in the US and Canada. Dr. Hodgson will deliver a 90-minute presentation and case review highlighting the essential role of IVUS and FFR in determining lesion severity and guiding proper stent placement and expansion entitled "IVUS and FFR: More Important than Ever. A Guide to Optimal PCI on the Eve of Second Generation DES".

Dr. Hodgson commented, "IVUS and FFR play an invaluable role in modern-day PCI. As practitioners, we are routinely misled by using angiography alone to assess lesion severity and confirm proper stent placement. Although IVUS and FFR have long been available to augment angiography, legacy systems were cumbersome, and access to these systems was too limited to drive broader acceptance."

Dr. Hodgson continued, "The combination of more complex target lesions, concerns about late stent thrombosis, the launch of new faster, integrated IVUS and FFR technologies, and the growing awareness that angiography does not tell the whole story, has driven IVUS use dramatically higher in recent years. It is no wonder that the use of IVUS has increased so rapidly."

The Volcano TLC speaker program with Dr. John Hodgson will visit the following cities over the next three months; New York City, Framingham, Buckhead, Miami, Baltimore, Nashville, Pittsburgh, Cleveland, Rosemont, Milwaukee, Houston, Dallas, Seattle, Las Vegas, San Francisco, Fresno, Montreal and Toronto. For specific dates, times and locations, please refer to the Volcano website at http://www.volcanocorp.com.

Availability

Volcano will highlight the new s5i integrated systems at the American College of Cardiology ACC Symposium in Chicago, March 29th to April 2nd. Volcano will have these new systems on display at Booth number #18093 for live demonstrations, as well as transmitting cases from ACC live broadcast sites. The Volcano s5-Revo and s5-FFR options complement the
'/>"/>

SOURCE Volcano Corporation Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5
Related biology technology :

1. Volcano Corporation Presentation at Bear Stearns Conference to be Webcast
2. Volcano Corporation Announces Pricing of Common Stock Offering
3. Volcano Announces Activities at TCT 2007: Expanded Role of IVUS in PCI to be Demonstrated
4. Volcano Announces Closing of CardioSpectra Acquisition
5. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
6. Volcano Announces FDA 510(k) Clearance of Revolution Rotational Catheter and FFR for the s5i Integrated IVUS Console
7. Volcano Corporation Presentation at Cowen Healthcare Conference to be Webcast
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.